Orthofix Medical (OFIX) Net Cash Flow (2010 - 2026)

Orthofix Medical has disclosed Net Cash Flow across 17 years of filings, most recently posting $35.8 million for Q1 2026.

• Quarterly Net Cash Flow rose 239.05% year-over-year to $35.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $59.6 million (up 91.29% YoY) and the FY2025 annual result came in at -$2.0 million, down 104.16% from the prior year.
• Net Cash Flow grew to $35.8 million in Q1 2026, from $19.2 million in the prior quarter.
• Over five years, Net Cash Flow peaked at $54.1 million in Q4 2024 and troughed at -$25.8 million in Q1 2025.
• A 5-year average of $1.9 million and a median of -$2.1 million in 2022 frame the typical range for Net Cash Flow.
• Annual changes were most pronounced in 2022 — Net Cash Flow slumped 1169.02% — and 2025, when it soared 1516.57%.
• Tracing OFIX's Net Cash Flow over 5 years: stood at -$2.1 million in 2022, then jumped by 272.01% to $3.5 million in 2023, then soared by 1430.77% to $54.1 million in 2024, then plunged by 64.49% to $19.2 million in 2025, then soared by 86.66% to $35.8 million in 2026.
• Business Quant data shows OFIX's Net Cash Flow at $35.8 million in Q1 2026, $19.2 million in Q4 2025, and -$2.6 million in Q3 2025.